Article
Cyp7b1-inhibiting azoles as novel enhancers of hematopoietic stem and progenitor cell mobilization
2025-10-14
Abstract excerpt
Mobilized hematopoietic stem and progenitor cells (HSPCs) are essential for transplantation-based therapies, including curative gene therapies for sickle cell disease (SCD). While granulocyte colony-stimulating factor (G-CSF, filgrastim) remains the standard mobilization agent, many patients respond inadequately, and it can trigger life-threatening vaso-occlusive crises in SCD. The CXCR4 antagonist AMD3100 (plerix...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 65d45971-4bd7-5634-a101-e19be367f3ea
- DOI
- 10.1101/2025.10.13.682145
